What does Shanghai ZJ Bio-Tech Co., Ltd. do?

Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 688317.SS's market cap?

Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) has a market capitalization of approximately $3.30 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 688317.SS pay a dividend?

Yes — Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 688317.SS profitable?

Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

688317.SS

Shanghai ZJ Bio-Tech Co., Ltd.

SHH·Biotechnology · Healthcare

¥17.36¥0.06−0.34%

Market cap¥3.30B·Market closed·Aug 26 7:00 AM UTC

Price Chart

¥17.36−¥0.06 (−0.34%)today

−67.20%CAGR −20.00%

Select date range

FromTo

Jan 18, 2021Aug 27, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.110

Ex-Dividend DateOct 18

Payment DateOct 18

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 13

Last Report DateApr 29

Reported vs Estimate−¥0.08

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥116.31M

Net Income−¥43.80M

Net Margin−37.7%

Operating Cash Flow¥61.19M

Capital Expenditures¥21.97M

Free Cash Flow¥39.22M

Return on Equity−1.3%

Return on Invested Capital−0.5%

Net Cash¥2.53B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 688317.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 688317.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 688317.SS and 80,000+ other tickers.

About Shanghai ZJ Bio-Tech Co., Ltd.

Shanghai ZJ Bio-Tech Co., Ltd., established in 2005 and headquartered in Shanghai, China, specializes in the innovation, manufacturing, and distribution of molecular genetic diagnostic reagents, alongside related instruments and equipment, specifically for the Chinese market.

CEO: Junbin Shao
Sector: Healthcare
Industry: Biotechnology
Exchange: SHH
Employees: 275
Website: www.liferiver.com.cn

Peers

Peers Tab

300878.SZ

Zhejiang Wecome Pharmaceutical Company Limited

Cap

¥4.6B

605199.SS

Hainan Huluwa Pharmaceutical Group Co., Ltd.

Cap

¥2.4B

688089.SS

Cabio Biotech (Wuhan) Co., Ltd.

Cap

¥1.3B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 688317.SS

What does Shanghai ZJ Bio-Tech Co., Ltd. do?: Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 688317.SS's market cap?: Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) has a market capitalization of approximately $3.30 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 688317.SS pay a dividend?: Yes — Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 688317.SS profitable?: Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.